All-In PodcastE113: DOJ tries to break up Google, vaccine questions, Ukraine escalation & more
Episode Details
EPISODE INFO
- Released
- January 27, 2023
- Duration
- 1h 38m
- Channel
- All-In Podcast
- Watch on YouTube
- ▶ Open ↗
EPISODE DESCRIPTION
(0:00) David Sacks does bestie intros! (2:49) DOJ sues Google over ads business (23:09) EU probes Microsoft over Slack complaint based on "bundling" Teams (40:27) Pfizer CEO grilled at Davos, analyzing studies questioning vaccine effectiveness (1:12:14) Ukraine escalation: US to send tanks and warms to Crimea invasion, reconstruction costs, and more (1:22:39) Science Corner: Will we soon be able to reverse aging? Follow the besties: https://twitter.com/chamath https://linktr.ee/calacanis https://twitter.com/DavidSacks https://twitter.com/friedberg Follow the pod: https://twitter.com/theallinpod https://linktr.ee/allinpodcast Intro Music Credit: https://rb.gy/tppkzl https://twitter.com/yung_spielburg Intro Video Credit: https://twitter.com/TheZachEffect Referenced in the show: https://thebulletin.org/2023/01/press-release-doomsday-clock-set-at-90-seconds-to-midnight https://www.nytimes.com/2023/01/24/us/doomsday-clock-midnight.html https://www.wsj.com/articles/u-s-sues-google-for-alleged-antitrust-violations-in-its-ad-tech-business-11674582792 https://blog.google/outreach-initiatives/public-policy/doj-ad-tech-lawsuit-response https://noahpinion.substack.com/p/would-breaking-up-google-really-do https://thehustle.co/12232022-ad-spend https://www.adweek.com/programmatic/advertisers-sweet-tooth-fades-with-many-unfazed-by-googles-latest-cookie-removal-delay https://www.politico.eu/article/microsoft-european-union-antitrust-video-calls-software-giant https://twitter.com/rebelnewsonline/status/1615770518606561282 https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.122.061025 https://www.nature.com/articles/s41467-022-31401-5 https://www.seacoastonline.com/story/opinion/columns/2022/01/29/kerr-covid-vaccines-anti-vaxxers-should-reject-hospital-beds-too/9246198002/ https://www.cnn.com/videos/media/2021/12/05/marcus-lamb-death-covid-19-vaccines-rs-vpx.cnn https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9451592 https://twitter.com/jason/status/1478587551271161857 https://twitter.com/EricTopol/status/1618381912413962240 https://www.cnbc.com/2023/01/25/ukraine-war-news-us-will-send-abrams-tanks.html https://www.businessinsider.com/ukraine-now-getting-western-tanks-looking-at-fighter-jets-next-2023-1 https://www.nytimes.com/2023/01/18/us/politics/ukraine-crimea-military.html https://www.dailymail.co.uk/debate/article-11661589/PETER-HITCHENS-Sending-Ukraine-tanks-turn-Europe-one-big-radioactive-graveyard.html https://twitter.com/DavidSacks/status/1618321900324950018 https://intellinews.com/ukraine-spiralling-towards-default-according-to-fitch-267768 https://www.wsj.com/articles/roman-abramovich-ukraine-russia-peace-sanctions-11674572583 https://www.cell.com/cell/fulltext/S0092-8674(22)01570-7#%20 #allin #tech #news
SPEAKERS
Jason Calacanis
hostDavid Friedberg
hostChamath Palihapitiya
hostUnknown guest at Davos questioning Pfizer CEO
guest
EPISODE SUMMARY
In this episode of All-In Podcast, featuring Jason Calacanis and David Sacks, E113: DOJ tries to break up Google, vaccine questions, Ukraine escalation & more explores all-In breaks down Google antitrust, vaccine fallout, Ukraine escalation, aging science This All-In episode covers four major threads: the DOJ’s new antitrust case against Google’s ad business and the EU probe into Microsoft’s bundling of Teams; a long, contentious reassessment of COVID vaccines, mandates, and institutional trust; mounting escalation and endgame scenarios in the Ukraine–Russia war; and breakthrough aging research around epigenetics and Yamanaka factors. The besties mostly argue that the Google ad suit is ill-targeted, but see more merit in regulating specific anti-competitive tactics like bundling and opaque enterprise licenses. On COVID, they agree the vaccines were over‑sold on transmission, mandates were overreach, and the fallout is eroding trust in authorities. They close with cautious optimism that aging-reversal therapies will create real health and investment opportunities over the coming decades.
RELATED EPISODES
